Login to Your Account



Patent disclosures


Wednesday, February 12, 2014

Biondvax Pharmaceuticals Ltd., of Nes Ziona, Israel, received approval from Hong Kong’s patent office to register its patent covering Multimeric Multiepitopes for the company’s universal flu vaccine.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription